Whole-blood model

C A Ison1

  • 1Department of Infectious Diseases ⇐p; Microbiology, Imperial College School of Medicine, London, UK.

Insights

Neisseria meningitidis can be harmless or cause disease. Immunity to serogroup B infections relies on outer-membrane proteins and phagocytosis, as its capsular polysaccharide is non-immunogenic.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogen Research

Background:

  • Neisseria meningitidis is a human pathogen that can be commensal or invasive.
  • Immunity to serogroup A and C is mediated by antibodies to capsular polysaccharide (CPS).
  • Serogroup B's CPS is non-immunogenic due to resemblance to host moieties, necessitating alternative immunity mechanisms.

Purpose of the Study:

  • To investigate alternative mechanisms of immunity against Neisseria meningitidis serogroup B infections.
  • To explore the role of outer-membrane proteins (OMPs) in host defense.
  • To understand the significance of cellular defense mechanisms like phagocytosis.

Main Methods:

  • Analysis of bacterial cell envelope components.
  • Investigation of host immune responses.
  • Studies on phagocytic activity against Neisseria meningitidis.

Main Results:

  • Capsular polysaccharide (CPS) of serogroup B is non-immunogenic.
  • Outer-membrane proteins (OMPs) are implicated in immunity.
  • Phagocytosis plays a role in host defense against serogroup B.

Conclusions:

  • Immunity to Neisseria meningitidis serogroup B infections is not dependent on CPS antibodies.
  • Outer-membrane proteins and phagocytosis are key components of the immune response.
  • Further research into OMPs and phagocytosis is crucial for developing serogroup B vaccines.